Non-linear transcriptional responses to gradual modulation of transcription factor dosage

Júlia Domingo,Mariia Minaeva,John A. Morris,Samuel Ghatan,Marcello Ziosi,Neville E. Sanjana,Tuuli Lappalainen

DOI: https://doi.org/10.1101/2024.03.01.582837

2024-08-06

Abstract:Genomic loci associated with common traits and diseases are typically non-coding and likely impact gene expression, sometimes coinciding with rare loss-of-function variants in the target gene. However, our understanding of how gradual changes in gene dosage affect molecular, cellular, and organismal traits is currently limited. To address this gap, we induced gradual changes in gene expression of four genes using CRISPR activation and inactivation. Downstream transcriptional consequences of dosage modulation of three master trans-regulators associated with blood cell traits (GFI1B, NFE2, and MYB) were examined using targeted single-cell multimodal sequencing. We showed that guide tiling around the TSS is the most effective way to modulate cis gene expression across a wide range of fold-changes, with further effects from chromatin accessibility and histone marks that differ between the inhibition and activation systems. Our single-cell data allowed us to precisely detect subtle to large gene expression changes in dozens of trans genes, revealing that many responses to dosage changes of these three TFs are non-linear, including non-monotonic behaviours, even when constraining the fold-changes of the master regulators to a copy number gain or loss. We found that the dosage properties are linked to gene constraint and that some of these non-linear responses are enriched for disease and GWAS genes. Overall, our study provides a straightforward and scalable method to precisely modulate gene expression and gain insights into its downstream consequences at high resolution.

Genomics

What problem does this paper attempt to address?

The paper aims to explore the nonlinear transcriptional responses generated by gradually changing the gene dosage of transcription factors on downstream molecular, cellular, and organismal characteristics. Specifically, the study focuses on the following key points: 1. **Research Background and Motivation**: Most genetic variations associated with complex diseases are located in non-coding regions and may affect gene expression. However, our understanding of how gradual changes in gene dosage influence downstream phenotypes is still limited. 2. **Research Methods**: By using CRISPR activation (CRISPRa) and inhibition (CRISPRi) techniques, the expression levels of four genes (GFI1B, NFE2, MYB, and TET2) were gradually altered, and targeted single-cell multi-modal sequencing was used to analyze the effects of these changes on downstream gene expression. 3. **Main Findings**: - The study shows that designing sgRNAs around the transcription start site (TSS) is the most effective method for regulating cis-gene expression over a broad range of fold changes. - After adjusting the gene dosage of three master transcriptional regulators of blood cell traits (GFI1B, NFE2, and MYB), many responses were observed to be nonlinear, including non-monotonic behaviors. - Nonlinear responses are associated with gene constraints, and some nonlinear responses are enriched in disease genes. - The study provides a simple and scalable method to precisely regulate gene expression and gain insights into its downstream effects. In summary, this study reveals the widespread presence of nonlinear transcriptional responses by precisely controlling changes in transcription factor gene dosage, which helps to understand how genetic variations influence human diseases.

Non-linear transcriptional responses to gradual modulation of transcription factor dosage

Functional Inference of Gene Regulation Using Single-Cell Multi-Omics

Single-cell Multi-Scale Footprinting Reveals the Modular Organization of DNA Regulatory Elements

Parameterizing Cell-to-cell Regulatory Heterogeneities Via Stochastic Transcriptional Profiles

High-resolution profiling reveals coupled transcriptional and translational regulation of transgenes

Genome-wide nucleosome and transcription factor responses to genetic perturbations reveal chromatin-mediated mechanisms of transcriptional regulation

Rewriting regulatory DNA to dissect and reprogram gene expression

Extending the dynamic range of transcription factor action by translational regulation

Discovery of target genes and pathways of blood trait loci using pooled CRISPR screens and single cell RNA sequencing

Elastic dosage compensation by X-chromosome upregulation

Evolution of dosage-sensitive genes by tissue-restricted expression changes

Transfer learning reveals sequence determinants of the quantitative response to transcription factor dosage

Inferring gene regulation from stochastic transcriptional variation across single cells at steady state

Buffering and non-monotonic behavior of gene dosage response curves for human complex traits

A refined method to study gene dosage changes in vitro using CRISPR/Cas9

Gene regulatory network inference from CRISPR perturbations in primary CD4+ T cells elucidates the genomic basis of immune disease

Nonlinear control of transcription through enhancer–promoter interactions

Functional dynamic genetic effects on gene regulation are specific to particular cell types and environmental conditions

The Functional Consequences of Variation in Transcription Factor Binding

Transcription factor networks disproportionately enrich for heritability of blood cell phenotypes

Genetic variants associated with cell-type-specific intra-individual gene expression variability reveal new mechanisms of genome regulation